MED: Medifast, Inc.
About
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.
Current Value
$17.181 Year Return
Current Value
$17.181 Year Return
Key Details
Market Cap
$189.44M
P/E Ratio
25.92
1Y Stock Return
-73.66%
1Y Revenue Growth
-44.64%
Dividend Yield
7.36%
Price to Book
0.9
Strategies that include MED
Stock's related to MED
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TDOC | 43.38% | $1.54B | -47.22% | 0.00% |
| GEHC | 41.22% | $37.70B | +12.46% | 0.15% |
| CHGG | 39.12% | $175.24M | -83.42% | 0.00% |
| MFIN | 36.74% | - | - | 4.31% |
| TAP | 35.44% | $12.53B | +2.00% | 2.85% |
| LOVE | 35.24% | $513.90M | +78.25% | 0.00% |
| STKS | 34.69% | $93.49M | -36.08% | 0.00% |
| LESL | 34.22% | $532.55M | -48.75% | 0.00% |
| FORR | 34.15% | $313.81M | -33.68% | 0.00% |
| NUS | 33.89% | $377.31M | -55.82% | 7.56% |
| XPER | 33.52% | $378.82M | -19.06% | 0.00% |
| ONL | 32.40% | $218.76M | -20.85% | 10.31% |
| NXDT | 32.37% | $218.01M | -37.42% | 11.58% |
| SPTN | 32.26% | $615.01M | -17.44% | 4.80% |
| RGP | 31.39% | $276.47M | -41.17% | 6.78% |
| COUR | 31.35% | $1.08B | -64.26% | 0.00% |
| EGHT | 31.27% | $351.48M | -7.88% | 0.00% |
| CDXS | 30.94% | $345.86M | +121.35% | 0.00% |
| TG | 30.93% | $244.31M | +47.82% | 0.00% |
| CYH | 30.69% | $529.39M | +35.59% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EW | -0.03% | $41.40B | +4.84% | 0.00% |
| ALAR | 0.07% | $89.09M | +158.08% | 0.00% |
| GPCR | 0.09% | $1.88B | -36.14% | 0.00% |
| API | -0.09% | $299.01M | +33.12% | 0.00% |
| AVAV | 0.13% | $5.50B | +51.29% | 0.00% |
| SAR | -0.13% | - | - | 11.52% |
| JNPR | -0.17% | $11.61B | +30.55% | 2.49% |
| GALT | 0.17% | $172.91M | +41.28% | 0.00% |
| STNG | -0.17% | $2.96B | +0.87% | 2.75% |
| MA | -0.18% | $476.78B | +27.02% | 0.51% |
| GAN | 0.20% | $83.39M | +21.19% | 0.00% |
| TRI | -0.23% | $72.33B | +16.06% | 1.01% |
| MSFT | -0.25% | $3.11T | +11.99% | 0.54% |
| ORCL | -0.29% | $523.45B | +62.73% | 0.84% |
| CPSH | 0.29% | $20.70M | -40.13% | 0.00% |
| ACAD | 0.35% | $2.70B | -27.80% | 0.00% |
| WMT | -0.40% | $696.11B | +66.69% | 1.38% |
| V | 0.41% | $595.29B | +23.64% | 0.69% |
| NRG | -0.45% | $19.22B | +109.87% | 1.71% |
| QNTM | 0.47% | $9.19M | -94.36% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MAX | -19.53% | $681.47M | +32.02% | 0.00% |
| LLY | -15.44% | $692.74B | +23.14% | 0.71% |
| CCEC | -14.22% | $1.02B | +28.03% | 3.26% |
| MCK | -14.09% | $78.15B | +35.51% | 0.42% |
| CYD | -14.01% | $364.46M | -2.94% | 4.26% |
| MNR | -12.52% | $1.66B | -10.71% | 15.90% |
| CANG | -11.55% | $253.50M | +212.50% | 0.00% |
| NVO | -11.52% | $342.62B | -0.15% | 1.40% |
| TT | -11.10% | $92.94B | +82.73% | 0.79% |
| SEVN | -10.42% | $193.74M | +16.70% | 10.77% |
| COST | -9.81% | $412.13B | +62.81% | 0.49% |
| X | -9.64% | $8.76B | +13.32% | 0.51% |
| STG | -9.50% | $35.67M | +7.92% | 0.00% |
| LDOS | -9.43% | $21.12B | +49.80% | 0.96% |
| ECL | -9.40% | $69.18B | +30.92% | 0.93% |
| ACGL | -9.29% | $36.00B | +16.84% | 0.00% |
| COR | -9.26% | $47.48B | +21.20% | 0.86% |
| ATI | -8.09% | $8.31B | +32.37% | 0.00% |
| VTYX | -7.91% | $125.87M | -23.61% | 0.00% |
| HESM | -7.66% | $3.78B | +14.54% | 7.24% |
ETF's related to MED
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SMDV | 37.90% | $754.57M | 0.4% |
| XSHD | 37.31% | $54.49M | 0.3% |
| ZIG | 36.44% | $52.15M | 0.84% |
| GSSC | 36.42% | $529.86M | 0.2% |
| IVOV | 36.42% | $964.95M | 0.15% |
| RZV | 36.30% | $258.76M | 0.35% |
| SMLF | 36.10% | $1.44B | 0.15% |
| SDVY | 36.03% | $7.17B | 0.6% |
| XRT | 35.83% | $451.85M | 0.35% |
| XSLV | 35.76% | $322.27M | 0.25% |
| IJS | 35.53% | $7.37B | 0.18% |
| VIOV | 35.45% | $1.44B | 0.15% |
| SLYV | 35.33% | $4.16B | 0.15% |
| RWJ | 34.91% | $1.75B | 0.39% |
| CALF | 34.60% | $8.93B | 0.59% |
| FREL | 33.97% | $1.06B | 0.084% |
| VNQ | 33.94% | $36.36B | 0.12% |
| EFAA | 33.87% | $117.38M | 0% |
| PEY | 33.57% | $1.24B | 0.53% |
| REET | 33.49% | $3.83B | 0.14% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| CORN | 0.01% | $61.12M | 0.2% |
| ULST | -0.02% | $535.47M | 0.2% |
| FLTR | -0.24% | $1.79B | 0.14% |
| IBTE | 0.53% | $1.70B | 0.07% |
| PWZ | -0.62% | $697.36M | 0.28% |
| DBA | 0.73% | $755.88M | 0.93% |
| FLOT | 0.84% | $7.31B | 0.15% |
| IBD | -1.09% | $330.68M | 0.44% |
| YOLO | -1.29% | $34.71M | 1.03% |
| IBDP | 1.50% | $2.11B | 0.1% |
| FLRT | 1.52% | $401.26M | 0.6% |
| TAIL | 1.54% | $67.98M | 0.59% |
| XHLF | 1.69% | $874.27M | 0.03% |
| DBMF | -1.75% | $1.02B | 0.85% |
| DBO | 1.83% | $217.57M | 0.77% |
| PREF | -1.86% | $999.92M | 0.55% |
| SEIX | -1.87% | $268.81M | 0.62% |
| GSG | 1.87% | $914.42M | 0.75% |
| JBBB | -2.05% | $1.26B | 0.49% |
| CANE | 2.37% | $17.72M | 0.29% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -24.97% | $388.04M | 1.43% |
| USDU | -24.41% | $201.97M | 0.5% |
| UUP | -24.01% | $309.25M | 0.77% |
| EQLS | -13.69% | $76.08M | 1% |
| BSCO | -11.22% | $2.35B | 0.1% |
| DUSB | -9.81% | $797.63M | 0.15% |
| BOXX | -6.96% | $4.43B | 0.1949% |
| CNBS | -6.93% | $21.10M | 0.77% |
| MSOS | -6.82% | $632.80M | 0.83% |
| CLOI | -6.55% | $715.40M | 0.4% |
| MINT | -6.52% | $11.62B | 0.35% |
| AGZD | -6.46% | $142.76M | 0.23% |
| IBHD | -6.31% | $327.80M | 0.35% |
| DBE | -6.19% | $50.13M | 0.77% |
| VIXY | -6.15% | $195.31M | 0.85% |
| KRBN | -6.15% | $242.47M | 0.85% |
| UNG | -6.12% | $908.80M | 1.06% |
| TBIL | -5.72% | $4.38B | 0.15% |
| SGOV | -5.60% | $27.53B | 0.09% |
| FLRN | -4.24% | $2.33B | 0.15% |
News
Yahoo
MED is battling customer acquisition challenges and high SG&A costs, while its strategic growth efforts keep it well-positioned for long-term success.
Yahoo
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Medifast (NYSE:MED).
Yahoo
Medifast ( NYSE:MED ) Third Quarter 2024 Results Key Financial Results Revenue: US$140.2m (down 41% from 3Q 2023). Net...
SeekingAlpha
Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive opportunity for investors. Read more here.
Fintel
DA Davidson Upgrades Medifast (MED)
Yahoo
Despite a significant revenue drop, Medifast Inc (MED) focuses on innovation and strategic marketing to counteract market pressures and competition.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.